Dapagliflozin reduces the amplitude of shortening and Ca2+ transient in ventricular myocytes from streptozotocin-induced diabetic rats

Effects of exercise training on excitation–contraction coupling and related mRNA expression in hearts of Goto-Kakizaki type 2 diabetic rats

(2013) K. A. Salem et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Effects of SGLT2 inhibitors on cardiovascular outcomes

(2012) Celine Foote et al.   Diabetes & Vascular Disease Research

Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise

(2012) K. Stenlöf et al.   DIABETES OBESITY & METABOLISM

Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes

(2012) Christine Clar et al.   BMJ Open

A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of randomized trials

(2011) Giovanni Musso et al.   ANNALS OF MEDICINE

Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes

(2011) Muhammad A. Abdul-Ghani et al.   ENDOCRINE REVIEWS

Structural lesions and changing pattern of expression of genes encoding cardiac muscle proteins are associated with ventricular myocyte dysfunction in type 2 diabetic Goto-Kakizaki rats fed a high-fat diet

(2011) Frank C. Howarth et al.   EXPERIMENTAL PHYSIOLOGY

Evaluation of the effect of dapagliflozin on cardiac repolarization: a thorough QT/QTc study

(2011) Glenn F. Carlson et al.   Diabetes Therapy

Effects of GH Secretagogues on Contractility and Ca2+Homeostasis of Isolated Adult Rat Ventricular Myocytes

(2010) Qiang Sun et al.   ENDOCRINOLOGY

Functional effects of glucose transporters in human ventricular myocardium

(2010) Dirk von Lewinski et al.   EUROPEAN JOURNAL OF HEART FAILURE

Glucose-transporter–mediated positive inotropic effects in human myocardium of diabetic and nondiabetic patients

(2010) Dirk von Lewinski et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members

(2010) Jian Chen et al.   Diabetes Therapy

SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states

(2009) S. K. Banerjee et al.   CARDIOVASCULAR RESEARCH

L-type calcium channel current up-regulation by chronic stress is associated with increased α1c subunit expression in rat ventricular myocytes

(2008) Yun Zhao et al.   CELL STRESS & CHAPERONES

Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes

(2008) Wei Meng et al.   JOURNAL OF MEDICINAL CHEMISTRY

Myofilament sensitivity to Ca2+ in ventricular myocytes from the Goto–Kakizaki diabetic rat

(2008) Frank Christopher Howarth et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY